3Lee DH, Ha MH, Christiani DC. Body weight, alcohol consumption and liver enzyme activity-a 4-year follow-up study [ J]. Int J Epidemiol,2001,30 (4) :766-770
4Cable R, Badon S, Pray C, et al. Limited utility of alanine aminotranseferase screening of hepatitis C antibody screened btood donors. Transfusion, 1997,37 ( 2 ) :206-210
5Kao JH, Chen PJ, Lai MY, et al. Genotypes and clinical phenotypes of hepatitis virus in patients with chronic hepatitis B virus infection[ J]. J Clin Microbiol 2002,40(4) : 1207-1209
6Angulo P, Keaeh JC, Batts KP, et al. Independent predictors of liver fibrosis in patientswith nonalcoholic steatohepatitis[J].Hepatology, 1999, 30(6): 1356-1362.
7Orellana NI, Poniachik T J, Smok SG, et al. Factors associated with the severity of liver damage in chronid hepatis C [J]. Rev Med Chil, 2005, 133(11): 1311-1316.
8Adinolfi LE, Utili R, Andreana A, et al. Serum HCV RNA levels correlate with histological liver damdge and concur with steatosis in progression of chronic hepatitis C [J]. Dig Dis Sci, 2001, 46(8): 1677-1683.
9Puoti C, Magrini A, Stati T, et al. Clinical, histological, and virological features of hepatitis C virus carriers with persistently normal or abnormal alanine transaminase levels [J]. Hepatology, 1997, 26(6): 1393-1398.
10Kao JH,Chen PJ,Lai MY,et a1.Genotypes and clinical pheno-types of hepatitis virus in patients with chronic hepatitis B virus infection[J].J Clin Microbial 2002,40(4):1207.
